Overview

Condition lung cancer
Treatment spectrum image analysis using a linear array ultrasound bronchoscope
Sponsor University Health Network, Toronto
Start date September 2013
End date January 2018
Trial size 300 participants
Trial identifier NCT01972386, 12-5898-CE

Summary

To evaluate the clinical benefit of spectrum analysis of endobronchial ultrasound images of lymph nodes during EBUS TBNA for lymph node staging in patients with lung cancer.

Recruiting in the following locations…

United States No locations recruiting
Other Countries Canada

Study Design

Observational model case-only
Time perspective prospective
Arm
spectrum image analysis using a linear array ultrasound bronchoscope

Primary Outcomes

Measure
Lymph Node Staging
time frame: Pathology report will be completed as soon as possible after the procedure. (Within one year)

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Ages 18 years or older - Patients with known or suspected lung cancer who require EBUS-TBNA for lymph node staging Exclusion Criteria: - Patients who are deemed on clinical grounds not to be medically fit for a bronchoscopy - Inability to give informed consent - Patients who are pregnant

Additional Information

Official title Spectrum Image Analysis of Lymph Nodes During Endobronchial Ultrasound-Guided (EBUS) Transbronchial Needle Aspiration (TBNA) in Patients With Lung Cancer
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by University Health Network, Toronto.